Table 3.
p Value of MVPA × BMI interaction term | Stratification | HbA1c (dual units) | MVPA (30 min/day) |
BMI (1 kg/m2) |
||
---|---|---|---|---|---|---|
Beta (99% CI)* | p Value | Beta (99% CI)† | p Value | |||
0.004 | BMI<30.0 kg/m2 | (mmol/mol) (%) |
−0.7
(−1.2 to −0.1) −0.06 (−0.11 to −0.01) |
0.002 | – | – |
BMI≥30.0 kg/m2 | (mmol/mol) (%) |
−1.5 (−2.3 to −0.6) −0.13 (−0.21 to −0.05) |
<0.001 | – | – | |
MVPA<150 mins/week | (mmol/mol) (%) | – | – |
0.2 (0.1 to 0.3) 0.02 (0.01 to 0.03) |
<0.001 | |
MVPA≥150 mins/week | (mmol/mol) (%) | – | – |
0.2 (0.1 to 0.3) 0.02 (0.01 to 0.03) |
<0.001 |
All analyses controlled for primary sampling units, clustering and survey weights. Bold indicates statistical significance at p<0.01. Models adjusted for: age, ethnicity, income, sex, any prescribed medication and accelerometer wear-time.
*Beta coefficients represent the average difference in HbA1c (mmol/mol) (%) for each 30 min/day increment in MVPA.
†Beta coefficients represent the average difference in HbA1c (mmol/mol) (%) for each 1 kg/m2 increment in BMI.